Cytochrome P450 2B6 genetic variants are associated with plasma nevirapine levels and clinical response in HIV-1 infected Kenyan women: a prospective cohort study.

Oluka, Margaret Ngwono; Okalebo, Faith Apolot; Guantai, Anastasia Nkatha; McClelland, R Scott; Graham, Susan M

Oluka, Margaret Ngwono; Okalebo, Faith Apolot; Guantai, Anastasia Nkatha; McClelland, R Scott; Graham, Susan M.

Afiliação

Oluka MN; Department of Pharmacology and Pharmacognosy, University of Nairobi, P.O. BOX 19498, Nairobi, 00202 Kenya.
Okalebo FA; Department of Pharmacology and Pharmacognosy, University of Nairobi, P.O. BOX 19498, Nairobi, 00202 Kenya.
Guantai AN; Department of Pharmacology and Pharmacognosy, University of Nairobi, P.O. BOX 19498, Nairobi, 00202 Kenya.
McClelland RS; Departments of Medicine, Global Health, and Epidemiology, University of Washington, Seattle, USA and Institute of Tropical and Infectious Diseases, University of Nairobi, Nairobi, Kenya.
Graham SM; Departments of Medicine, Global Health, and Epidemiology, University of Washington, Seattle, USA and Institute of Tropical and Infectious Diseases, University of Nairobi, Nairobi, Kenya.

AIDS Res Ther ; 12: 10, 2015.

Article em En | MEDLINE | ID: mdl-25878720

Palavras-chave

Antiretroviral therapy; CYP2B6; HIV infection; Nevirapine; Pharmacogenetics; Women

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google